Press release
Diabetes Clinical Trials | A Drug Pipeline Analysis Report 2024 | Daewoong, Janssen Biotech, and others
Diabetes Pipeline Analysis Report 2024
Download sample report @ https://www.delveinsight.com/report-store/diabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Key Takeaways from the Diabetes Pipeline Report
Over 200+ Diabetes pipeline therapies are in various stages of development, and their anticipated acceptance in the Diabetes market would significantly increase market revenue.
Leading Diabetes companies developing novel drug candidates to improve the Diabetes treatment landscape include Daewoong, Janssen Biotech, and others.
Promising Diabetes pipeline therapies in various stages of development include Enavogliflozin, Golimumab, and others.
Diabetes Overview
Diabetes mellitus, commonly referred to as diabetes, is a chronic metabolic disorder characterized by high blood sugar (glucose) levels over a prolonged period. There are several types of diabetes, with the two main types being Type 1 and Type 2 diabetes. Here's an overview covering their causes, signs and symptoms, diagnosis, and treatment options:
Types of Diabetes:
1. Type 1 Diabetes:
- Cause: Type 1 diabetes results from an autoimmune destruction of insulin-producing beta cells in the pancreas. The exact cause is not fully understood, but genetics and environmental factors (such as viral infections) play a role.
- Onset: It often develops in childhood or adolescence, but can occur at any age.
- Treatment: Requires lifelong insulin therapy to manage blood sugar levels.
2. Type 2 Diabetes:
- Cause: Type 2 diabetes develops when the body becomes resistant to insulin or when the pancreas fails to produce enough insulin. Risk factors include obesity, sedentary lifestyle, genetics, and age.
- Onset: It typically develops in adults, but is increasingly seen in younger individuals due to rising obesity rates.
- Treatment: Initially managed with lifestyle changes (diet and exercise) and may require oral medications or insulin as the disease progresses.
Diabetes Signs and Symptoms:
1. Common symptoms of diabetes include:
- Increased thirst (polydipsia)
- Frequent urination (polyuria)
- Extreme hunger (polyphagia)
- Unexplained weight loss
- Fatigue and weakness
- Blurred vision
- Slow healing of wounds
- Recurrent infections, such as yeast infections
Diabetes Diagnosis:
1. Blood Tests:
- Fasting Plasma Glucose Test: Measures blood sugar levels after fasting for at least 8 hours.
- A1C Test: Reflects average blood sugar levels over the past 2-3 months.
- Oral Glucose Tolerance Test (OGTT): Measures blood sugar levels before and after consuming a sugary drink.
2. Other Diagnostic Tests:
- C-peptide Test: Measures how much insulin the pancreas is producing.
Treatment Options:
1. Type 1 Diabetes:
- Insulin Therapy: Daily injections or use of an insulin pump to replace the insulin the body is unable to produce.
- Continuous Glucose Monitoring (CGM): Devices that monitor blood sugar levels throughout the day and night.
2. Type 2 Diabetes:
- Lifestyle Changes: Healthy diet, regular physical activity, and weight management.
- Oral Medications: Metformin and other medications that help improve insulin sensitivity or decrease glucose production in the liver.
- Insulin Therapy: May be necessary if oral medications are not sufficient to control blood sugar levels.
3. Additional Treatments for Both Types:
- Blood Pressure and Cholesterol Management: To reduce the risk of cardiovascular complications.
- Regular Monitoring and Diabetes Education: To learn about managing the disease and preventing complications.
- Bariatric Surgery: Considered in some cases of Type 2 diabetes with severe obesity.
Diabetes Market Outlook:
With proper management, people with diabetes can live healthy and fulfilling lives. However, diabetes requires lifelong monitoring and adherence to treatment regimens to prevent complications such as cardiovascular disease, kidney disease, nerve damage (neuropathy), and vision loss (diabetic retinopathy). Early diagnosis, lifestyle modifications, and timely medical interventions are key to managing diabetes effectively and reducing its impact on overall health.
Request for a sample report on diabetes pipeline insights @ https://www.delveinsight.com/report-store/diabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Diabetes Pipeline Analysis: Drug Profile
Enavogliflozin - Daewoong
Enavogliflozin (DWP 16001) is an orally available small molecule and sodium glucose transporter 2 inhibitor. The molecule is in phase-3 clinical trials for type-2 diabetic treatment. Enavogliflozin demonstrates the lowering of blood sugar and safety in diabetic patients in phase 2 clinical trials.
Discover more about the emerging Diabetes drugs @ https://www.delveinsight.com/sample-request/diabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Diabetes Key Companies
Daewoong
Janssen Biotech
Diabetes Pipeline Therapies
Enavogliflozin
Golimumab
Diabetes Pipeline Therapeutics Assessment
By development stage
By product type
By route of administration
By molecule type
By MOA type
Scope of the Diabetes Pipeline Report
Coverage: Global
Key Diabetes Companies: Daewoong, Janssen Biotech, and others
Key Diabetes Pipeline Therapies: Enavogliflozin, Golimumab, and others
Find out more about the Diabetes treatment options in development @ https://www.delveinsight.com/sample-request/diabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Table of Contents
1. Introduction
2. Executive Summary
3. Overview
4. Pipeline Therapeutics
5. Late-Stage Products (Phase III)
6. Mid-Stage Products (Phase II)
7. Early Stage Products (Phase I/II)
8. Preclinical Stage Products
9. Discovery Stage Products
10. Therapeutic Assessment
11. Inactive Products
12. Collaborations Assessment- Licensing / Partnering / Funding
13. Unmet Needs
14. Market Drivers and Barriers
15. Appendix
16. About DelveInsight
Download free sample report @ https://www.delveinsight.com/sample-request/diabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Trending Reports By DelveInsight:
Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market
Lebers Hereditary Optic Neuropathy Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market
Gastric Neuroendocrine Tumors Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market
Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market
Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market
Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market
Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market
Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market
Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market
Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market
Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market
Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market
Hypoplastic Left Heart Syndrome Hlhs Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market
Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market
Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market
Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market
Clinically Isolated Syndrome CIS Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market
Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market
Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market
Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market
Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market
Contact Us
Kritika Rehani
info@delveinsight.com
+14699457679
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetes Clinical Trials | A Drug Pipeline Analysis Report 2024 | Daewoong, Janssen Biotech, and others here
News-ID: 3753413 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Emerging trends for Diabetes Care Devices Market 2020 astonishing growth by Worl …
The global diabetes care devices market is expected to reach US$ 39,382.3 Mn in 2027 from US$ 23,354.3 Mn in 2018. The market is estimated to grow with a CAGR of 6.1% from 2020-2027.
Premium market insights recently published a report titled "Diabetes Care Devices Market Size and Forecast to 2026". The report includes an authentic and accurate research study into the global Diabetes Care Devices market based on a qualitative…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
